Download
1 / 5
50 likes | 52 Views
The Middle East and Africa Ventricular Assist Device was valued at USD xx million in 2018, and is projected to reach USD xx million by 2025, growing at a CAGR of 11.2% during 2018-2025.<br><br>The key factors boosting growth of the market are high prevalence of heart failures, rise in transition to minimally invasive surgical procedure from conventional surgeries, development of innovative approaches to treat various type of cardiac diseases. <br>Visit:u00a0https://www.gmiresearch.com/report/middle-east-and-africa-ventricular-assist-device-market-mea-vad/
E N D
Middle East and Africa Ventricular Assist Device Market
The high prevalence of heart failures, increasing transition to the minimally invasive surgical procedure from conventional surgeries, continuous development of innovative approaches to treat different type of cardiac diseases are the major key drivers responsible for the growth of the Middle East and Africa Ventricular Assist Device market share, in terms of revenue. Moreover, the rising number of patients waiting for heart transplantation and the introduction of new technologically advanced products such as Duraheart, Heartmate, among others, will further surge the market growth.
Middle East and Africa Ventricular Assist Device Market Summary The high prevalence of heart failures, increasing transition to the minimally invasive surgical procedure from conventional surgeries, continuous development of innovative approaches to treat different type of cardiac diseases are the major key drivers responsible for the growth of the Middle East and Africa Ventricular Assist Device market share, in terms of revenue. Moreover, the rising number of patients waiting for heart transplantation and the introduction of new technologically advanced products such as Duraheart, Heartmate, among others, will further surge the market growth.
Based on design type, the Implantable design segment is predicted to grow at a higher CAGR over the coming years. This is mainly due to the growing awareness related to the product in the field of interventional cardiology and the high cost-effectiveness of this type of design. On the other hand, the Transcutaneous design segment is anticipated to dominate the market as it provides several remarkable benefits as compared to the existing design type such as lowering of blood pressure, less bleeding, etc. In addition to this, the continuous advancement devices, for example, DuraHeart, HeartMate III, which incorporated features such as smaller size, lower rotational speeds, higher efficiency, and improved anatomic design, is positively influencing the growth of the segment.
About GMI Research GMI Research is a market research and consulting firm which provides bespoke industry & market research to help businesses in making the toughest business decision. We know the significance of accurate data; that’s why our analyst uses a tailored methodology to study every market in detail because one size doesn’t fit all. We not only cover the traditional well-established market but also focuses on the niche market and markets in the emerging economies, where getting data and information is a challenge. This factor makes us pioneer in emerging market research space. Our syndicate reports cover multiple industries across various regions and countries. Our in-depth market reports help propel your business with all the data, strategic inputs, and competitive intelligence to move ahead even in the most uncertain times. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research look forward to helping businesses stay ahead of the curve.
